Enzo Biochem Net Worth 2010-2023 | ENZ

Interactive chart of historical net worth (market cap) for Enzo Biochem (ENZ) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Enzo Biochem net worth as of March 30, 2023 is $0.12B.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.121B $0.107B
Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $143.445B 8.86
GSK (GSK) United Kingdom $75.664B 9.49
Bio-Rad Laboratories (BIO.B) United States $13.735B 32.61
QIAGEN (QGEN) Netherlands $10.416B 19.30
Ginkgo Bioworks Holdings (DNA) United States $2.487B 0.00
Arcus Biosciences (RCUS) United States $1.286B 0.00
Biohaven (BHVN) United States $0.930B 0.00
Emergent Biosolutions (EBS) United States $0.446B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.149B 0.00
SQZ Biotechnologies (SQZ) United States $0.017B 0.00
Gelesis Holdings (GLS) United States $0.014B 0.00